Profectus BioSciences Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Profectus BioSciences Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10841
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥54,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥81,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Profectus BioSciences Inc (Profectus) is a clinical-stage vaccine development company that designs and develops preventive and therapeutic vaccines for infectious diseases and oncolytic vaccines for cancer immunotherapy. The company’s products include genevax therapeutic vaccines, vesiculovax prophylactic vaccines and additional prophylactic vaccines. It uses PBS Vax technology platform for the development of new vaccines. Profectus’ products are used in the treatment of major chronic infectious diseases of public health and biodefense. The company also develops vaccines for pre- and post-exposure protection against the hemorrhagic disease caused by ebola and marburg viruses. It also develops oncolytic vaccines for cancer immunotherapy. The company partners with research laboratories and universities. Profectus is headquartered in Baltimore, Maryland, the US.

Profectus BioSciences Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Profectus BioSciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Profectus BioSciences Raises USD0.3 Million in Venture Financing 10
Profectus BioSciences Raises Additional USD0.2 Million in Financing Round 11
Profectus BioSciences Raises Additional USD0.2 Million in Financing Round 12
Profectus BioSciences Raises US$0.8 Million In Extended Series C Financing 13
Partnerships 14
CEPI Enters into Partnership with Profectus BioSciences and Emergent BioSolutions 14
CEPI Enters into Collaboration with Profectus BioSciences and Emergent BioSolutions 15
Profectus BioSciences Forms Joint Venture with Medisun Holdings 16
Profectus BioSciences Enters into Co-Development Agreement with Vyriad 17
Licensing Agreements 18
Profectus BioSciences Enters into Licensing Agreement with Henry M. Jackson 18
Profectus BioSciences Inc – Key Competitors 19
Profectus BioSciences Inc – Key Employees 20
Profectus BioSciences Inc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Joint Venture 21
Recent Developments 22
Clinical Trials 22
Jan 09, 2017: Profectus BioSciences Bivalent Vaccine Protects Animals from Infection and Death After Exposure to Chikungunya or Zika Virus 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Key Facts 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Profectus BioSciences Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Profectus BioSciences Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Profectus BioSciences Raises USD0.3 Million in Venture Financing 10
Profectus BioSciences Raises Additional USD0.2 Million in Financing Round 11
Profectus BioSciences Raises Additional USD0.2 Million in Financing Round 12
Profectus BioSciences Raises US$0.8 Million In Extended Series C Financing 13
CEPI Enters into Partnership with Profectus BioSciences and Emergent BioSolutions 14
CEPI Enters into Collaboration with Profectus BioSciences and Emergent BioSolutions 15
Profectus BioSciences Forms Joint Venture with Medisun Holdings 16
Profectus BioSciences Enters into Co-Development Agreement with Vyriad 17
Profectus BioSciences Enters into Licensing Agreement with Henry M. Jackson 18
Profectus BioSciences Inc, Key Competitors 19
Profectus BioSciences Inc, Key Employees 20
Profectus BioSciences Inc, Other Locations 21
Profectus BioSciences Inc, Joint Venture 21

List of Figures
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Profectus BioSciences Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Profectus BioSciences Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aeris Resources Limited:企業の戦略・SWOT・財務分析
    SummaryAeris Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key …
  • Par Petroleum Corporation (formerly Delta Petroleum Corporation):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Par Petroleum Corporation (form …
  • British Broadcasting Corporation:戦略・SWOT・企業財務分析
    British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report Summary British Broadcasting Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • DEXUS Property Group (formerly DB RREEF Trust):企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' DEXUS Property Group (formerly …
  • Portola Pharmaceuticals, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Portola Pharmaceuticals, Inc. M …
  • Ironhorse Oil & Gas Inc. (IOG):企業財務及び戦略的SWOT分析
    Summary Ironhorse Oil & Gas Inc. (Ironhorse) is an oil and natural gas exploration and production company that focuses on producing and developing acreage in west central Alberta. The company explores natural gas such as crude oil. Its projects include discovery of kiskatinaw liquids-rich gas pool t …
  • Time Warner Inc.:企業の戦略・SWOT・財務分析
    SummaryTime Warner Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Findin …
  • Santhera Pharmaceuticals Holding AG (SANN):製薬・医療:M&Aディール及び事業提携情報
    Summary Santhera Pharmaceuticals Holding AG (Santhera) develops and commercializes novel pharmaceutical products indicated for patients with mitochondrial and neuromuscular diseases. It specifically focuses in the area of neuromuscular and neuro-ophthalmological conditions. The company’s lead produc …
  • Castle Resources, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Castle Resources, Inc. Mergers …
  • The AES Corp:企業の発電所・SWOT分析2018
    The AES Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execu …
  • Mueller Water Products, Inc.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Mueller Water Products, Inc. Me …
  • Rubis S.C.A. (RUI):企業のM&A・提携動向(石油・ガス分野)
    Summary Rubis S.C.A. (Rubis) is an independent downstream company that carries out the storage, distribution and trading of bulk petroleum and chemical products. Its product portfolio includes fuel oil, liquefied petroleum gas (LPG), gasoline, diesel, home heating oil, chemical products and liquid f …
  • Sinovac Biotech Ltd.(製薬・医療分野):企業M&A動向
    Summary Sinovac Biotech Ltd (Sinovac Biotech) is a biopharmaceutical company. The company researches, develops, manufactures and commercializes vaccines that protect against human infectious diseases. Its products include Healive, an inactivated hepatitis A vaccine, Bilive, a combined inactivated he …
  • Oil States International, Inc.:企業の戦略・SWOT・財務情報
    Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report Summary Oil States International, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Singulus Technologies AG (SNG):企業のM&A・提携動向(発電分野)
    Summary Singulus Technologies AG (Singulus Technologies) is an optical disc production line manufacturer that develops technologies for efficient and resource-conserving production processes. The company offers optical disc solutions such as blu-ray disc, CD, and DVD production equipment. Its solar …
  • Elder Pharmaceuticals Ltd. (ELDERPHARM)(製薬・医療分野):企業M&A動向
    Summary Elder Pharmaceuticals Ltd. (Elder Pharma) is a pharmaceutical company. It manufactures and markets prescription pharmaceutical brands, surgical and medical devices. The product portfolio of the company includes amkey injection, bronchonil syrup, chymoral forte, chymoral plus, D360 sachets an …
  • Teco Energy Inc. (TE):企業の財務及び戦略的SWOT分析
    Teco Energy Inc. (TE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Global Nickel Investments Limited:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Global Nickel Investments Limit …
  • Wind River Energy Corp. (WVR):企業の財務及び戦略的SWOT分析
    Summary Wind River Energy Corp. (Wind River Energy), formerly Adcore Capital Inc., is an energy company that focuses on domestic energy projects in the US. It deals with the acquisition, exploration and development of oil and gas projects in Rocky Mountains and mid-continent regions in the US. Wind …
  • Harvard Pilgrim Health Care Inc:企業の戦略・SWOT・財務情報
    Harvard Pilgrim Health Care Inc - Strategy, SWOT and Corporate Finance Report Summary Harvard Pilgrim Health Care Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆